help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aljada, A.
Right arrow Articles by Dandona, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aljada, A.
Right arrow Articles by Dandona, P.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 12 5988
Copyright © 2001 by The Endocrine Society


RAPID COMMUNICATIONS

Hydrocortisone Suppresses Intranuclear Activator-Protein-1 (AP-1) Binding Activity in Mononuclear Cells and Plasma Matrix Metalloproteinase 2 and 9 (MMP-2 and MMP-9)

Ahmad Aljada, Husam Ghanim, Priya Mohanty, Debbie Hofmeyer, Devjit Tripathy and Paresh Dandona

Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, Buffalo, New York 14209

Abstract

Having demonstrated recently that hydrocortisone (HC) suppresses intranuclear and total cellular nuclear factor-{kappa}B (NF-{kappa}B) and increases inhibitor {kappa}B (I{kappa}B) in mononuclear cells (MNC), in vivo, we have now investigated the effect of hydrocortisone on the other major pro-inflammatory transcription factor, AP-1 and the two proteins, MMP-2 and MMP-9, whose transcription is modulated by it. MMP’s hydrolyze extracellular matrix proteins and thus, allow the spread of inflammation. HC (100 mg) was given intravenously to eight normal subjects following an overnight fast. Blood samples were obtained at 0, 1, 2, 4, 8 and 24 h. MNC were separated and the nuclear fractions and cellular homogenates were prepared by standard techniques. AP-1 binding activity was measured by electrophoretic mobility shift assay (EMSA). Plasma MMP-2 and MMP-9 were measured by ELISA. AP-1 binding activity fell significantly at 1, 2, 4 and 8 h. Plasma MMP-2 concentration also decreased significantly at 1, 2, 4 and 8 h while MMP-9 decreased at 1 and 2 h. These data demonstrate that the acute anti-inflammatory effect of HC, in vivo, is, in part, due to AP-1 suppression and a reduction in MMP-2 and MMP-9. Thus, HC may reduce the extracellular spread of inflammation through the inhibition of matrix metalloproteinases.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Mukherjee, J. T. Mingoia, J. A. Bruce, J. S. Austin, R. E. Stroud, G. P. Escobar, D. M. McClister Jr, C. M. Allen, M. A. Alfonso-Jaume, M. E. Fini, et al.
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2216 - H2228.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P. Girod and D. J. Brotman
Does altered glucocorticoid homeostasis increase cardiovascular risk?
Cardiovasc Res, November 1, 2004; 64(2): 217 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay
The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2422 - 2429.
[Full Text] [PDF]


Home page
Diabetes CareHome page
P. Dandona, A. Aljada, and A. Bandyopadhyay
The Potential Therapeutic Role of Insulin in Acute Myocardial Infarction in Patients Admitted to Intensive Care and in Those With Unspecified Hyperglycemia
Diabetes Care, February 1, 2003; 26(2): 516 - 519.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bozinovski, J. E. Jones, R. Vlahos, J. A. Hamilton, and G. P. Anderson
Granulocyte/Macrophage-Colony-stimulating Factor (GM-CSF) Regulates Lung Innate Immunity to Lipopolysaccharide through Akt/Erk Activation of NFkappa B and AP-1 in Vivo
J. Biol. Chem., November 1, 2002; 277(45): 42808 - 42814.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Koebernick, L. Grode, J. R. David, W. Rohde, M. S. Rolph, H.-W. Mittrucker, and S. H. E. Kaufmann
Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium
PNAS, October 15, 2002; 99(21): 13681 - 13686.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society